AptarGroup Inc (STU:AGT)
€ 134.9 1.7 (1.28%) Market Cap: 8.95 Bil Enterprise Value: 9.84 Bil PE Ratio: 31.23 PB Ratio: 4.10 GF Score: 89/100

Aptargroup Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 06:30PM GMT
Release Date Price: €113.4 (-0.26%)
Bhavana Balakrishnan

Good morning, everybody, and welcome to Day 4 of the JPMorgan Healthcare Conference. My name is Bhavana Balakrishnan, and I'm an associate in the Healthcare Investment Banking team. Thank you for joining us for the presentation of the AptarGroup. With us we have today is Stephan Tanda, who's the Chief Executive Officer; Bob Kuhn, who is the Chief Financial Officer; and Gael Touya, AptarGroup President. We'll have time at the end for questions. For now, over to you, Stephan.

Stephan B. Tanda
AptarGroup, Inc. - President, CEO & Executive Director

All right. Thank you, Bhavana. Thanks for having us back this year, and welcome, everybody, in the room and online. I'd love to give you an update on our pharma business.

You may not have heard of Aptar before, but you have a dozen of our products at home. I guarantee you. Anything from your nasal spray to your spray on suntan, to your upside down catch-up. But our largest business these days is pharma. And we serve the world's preeminent pharma company and global brands that you see up here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot